Our study is the first to show that monoclonal Igs may target the VP1 PALTAVETG and PALTAAETG epitopes of PV1/3 and CVB1/B3 in MGUS (6.5% cases) and to a lesser degree, in MM. The gene discussed is PLVAP; the disease is Miyoshi myopathy.